History

Affectis started operations in January 2004. The company is a spin-off from the Max-Planck-Institute of Psychiatry, a world renowned research center in the field of depression.

Affectis’ founders include Prof Florian Holsboer, a key opinion leader in psychiatry, Wolfgang Wurst, an expert in mouse genetics, and Herbert Stadler, an experienced entrepreneur who has founded a number of successful biopharmaceutical companies.

Affectis has unique capabilities in drug discovery and behavioural pharmacology, allowing the company to develop drugs with innovative mechanisms of action based on pioneering findings in the field of depression and inflammation.

The company is located in Martinsried near Munich, Germany.